Parry Nutraceuticals presents a new White Paper that outlines how Spirulina, dubbed a “Super Food,” supports the innate and acquired immune system’s army of Natural Killers, and adaptive T and B, cells. The paper helps to understand the specifics of Spirulina in molecular level action and its benefit towards - ani-bacterial, anti-viral and immune balancing effects.
Parry Nutraceuticals has 42+ years of experience in micro-algal technology and is a part of the 5.3 bn USD Murugappa group - one of India's leading business conglomerates. Valensa International is a wholly-owned subsidiary of Parry.
